Published Medical Treatment of Atopic Dermatitis This technology provides the first evidence that histamine-mediated skin barrier disruption is facilitated by histamine 4 receptor (H4R). By David Englert
Published Healthcare & Pharmaceuticals MiBiome topical suspension ClearSkin developed a completely new and unique therapy for treating chronic inflammatory skin diseases (e.g., psoriasis, atopic dermatitis, pruritus) using a novel topical probio By Milana Anash
Do you have an innovative technology, product or service? Add your solution to the world’s most advanced open innovation platform and get seen by global corporations seeking new solutions – all free of charge.
